Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of Views

<< 2012 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2014 >>

25 February 2013: Let's Look to the East - End, That is - for Lessons on Economic Recovery

By Stephen Caddick, Vice-Provost (Enterprise) at UCL
So the latest GDP figures show what we had all feared: that the Government's prescription to jolt the economy back to full health has failed and we are heading towards an unprecedented triple dip recession.
More...

<< 2012 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2014 >>